期刊文献+

医院感染革兰阳性球菌的耐药性及干预对策 被引量:12

Nosocomial infections caused by gram-positive cocci:antimicrobial resistance and intervention strategies
原文传递
导出
摘要 目的探讨医院感染革兰阳性球菌的构成比及耐药性,制定相关的医院感染干预对策。方法细菌培养与鉴定严格按照《全国临床检验操作规程》,采用常规方法进行;药物敏感试验采用CLSI推荐的K-B法,数据统计分析采用WHONET最新版本。结果 712株革兰阳性球菌中分离率居前3位分别为金黄色葡萄球菌、凝固酶阴性葡萄球菌、粪肠球菌,各占40.6%、31.9%、10.9%;革兰阳性球菌对常用抗菌药物表现出不同程度的耐药性,但对糖肽类抗菌药物万古霉素、替考拉宁100.0%敏感;MRSA检出率为60.9%,MRCNS检出率为61.2%。结论各级医疗机构应加大抗菌药物使用管理的力度,遏制细菌耐药率不断上升的不良趋势。 OBJECTIVE To study the constituent ratio and antimicrobial resistance of gram-positive cocci causing nosocomial infections in order to establish relative intervention strategies. METHODS Referring to National Guide to Clinical Laboratory Procedures,bacteria culture and identification were performed by the routine methods.The susceptibility test was performed by K-B method recommended by CLSI.The antimicrobial resistance profile was analyzed statistically by the latest version of WHONET software. RESULTS Among the 712 strains,the isolating rates of Staphylococcus aureus,coagulase-negative Staphylococcus,Enterococcus faecalis were 40.6%,31.9% and 10.9%,respectively.Gram-positive cocci were resistant to the commonly used antibiotics in varying degrees except for 100.0% susceptibility to vancomycin and teicoplanin.The detection rates of methicillin-resistant S.aureus(MRSA) and coagulase-negative Staphylococcus(MRCNS) were 60.9% and 61.2%,respectively. CONCLUSION Medical institutions should strengthen the antibiotic management to restrain the increasing tendency of resistance rates.
作者 鲁艳 李从荣
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第3期596-597,共2页 Chinese Journal of Nosocomiology
关键词 医院感染 革兰阳性球菌 构成比 耐药性 干预 Nosocomial infection Gram-positive coccus Constituent ratio Antimicrobial resistance Intervention
  • 相关文献

参考文献4

二级参考文献21

共引文献56

同被引文献71

  • 1郑惊雷,梁力建,赖佳明.胆道感染病原菌及其对抗生素敏感性变化的研究[J].中国实用外科杂志,2005,25(2):86-88. 被引量:51
  • 2杨青,俞云松,倪语星,孙景勇,徐英春,孙宏莉,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,卓超,苏丹虹,胡云建,艾效曼,黄文祥,贾蓓,张朝霞,季萍,张泓,李万华,魏莲花,吴玲,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET肠球菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):421-425. 被引量:61
  • 3Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in combined medical-surgical intensive care units in the United States [ J ]. Infect Control Hosp Epidemiol, 2000,21 ( 8 ) : 510 -515.
  • 4Wang JL, Hsueh PR. Therapeutic options for infections due to vancomycin-resistant enterococci [ J ]. Expert Opin Pharmacother, 2009,10 (5) :785-796.
  • 5Clinical and laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing [ S] . MI00-S20. CLSI, Wayne, PA. USA, 2010.
  • 6Clinical and laboratory Standards Institute. Performance Standardsfor Antimicrobial Susceptibility testing [S]. M100-S20. CLSI,2010.
  • 7Bertrand X. Methicillin-resistant Staphylococcus aureus : an ever emerging threat[J]. Future Medicine, 2010,7 (2) : 169- 178.
  • 8Clinical and laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-S20. CLSI, 2010.
  • 9Schneider J, De Waha P, Hapfelmeier A, et al. Risk factors for in- creased antimicrobial resistance: a retrospective analysis of 309 a- cute cholangitis episodes [ J ]. J Antimicrob Chemother, 2014, 69 (2) : 519-525.
  • 10Kang CI, Cha MK, Kim SH, et al. Clinical and molecular epide- miology of community-onset baeteremia caused by extended-spec- trum 13-1actamase-producing Escherichia coli over a 6-year period [J].J Korean Med Sci, 2013, 28(7): 998-1004.

引证文献12

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部